Kouchakji Elias Insider Trades

Insider Trading History

Track insider trading activity for Kouchakji Elias. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
FibroGen
FibroGen FGEN
Svp, Clinical Dev, Drug Safety
Holding Value $1.34M 147,346 shares
Last Trade
Mar 08, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.36M 5,221 shares
$834.25
$9.07
FibroGen
FibroGen FGEN
Svp, Clinical Dev, Drug Safety
Holding Value $1.38M 152,567 shares
Last Trade
Feb 24, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$52.9M 39,900 shares
$1,325.25
$9.07
FibroGen
FibroGen FGEN
Svp, Clinical Dev, Drug Safety
Holding Value $1.2M 131,767 shares
Last Trade
Dec 07, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.86M 2,728 shares
$1,049.75
$9.07
FibroGen
FibroGen FGEN
Svp, Clinical Dev, Drug Safety
Holding Value $1.22M 134,495 shares
Last Trade
Nov 17, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.81M 7,082 shares
$1,102.75
$9.07
FibroGen
FibroGen FGEN
Svp, Clinical Dev, Drug Safety
Holding Value $0 0 shares
Last Trade
Nov 17, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.81M 7,082 shares
$1,102.75
$9.07
FibroGen
FibroGen FGEN
Svp, Clinical Dev, Drug Safety
Holding Value $1.16M 127,413 shares
Last Trade
Sep 08, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.88M 2,728 shares
$1,054.00
$9.07

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up